Read + Share
Tomasini P, Wang Y, Li Y, Felip E, et al. Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung
Cancer: Results From CHRYSALIS-2. J Clin Oncol 2025 Dec 1:JCO2402835. doi: 10.1200/JCO-24-02835.
PMID: 41325571
|
 |
|
Tomasini P, Wang Y, Li Y, Felip E, et al. Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung
Cancer: Results From CHRYSALIS-2. J Clin Oncol 2025 Dec 1:JCO2402835. doi: 10.1200/JCO-24-02835.
PMID: 41325571
|
|
|
|